IL277973B2 - Evaporable formulation - Google Patents

Evaporable formulation

Info

Publication number
IL277973B2
IL277973B2 IL277973A IL27797320A IL277973B2 IL 277973 B2 IL277973 B2 IL 277973B2 IL 277973 A IL277973 A IL 277973A IL 27797320 A IL27797320 A IL 27797320A IL 277973 B2 IL277973 B2 IL 277973B2
Authority
IL
Israel
Prior art keywords
alkyl
group
vaporisable formulation
cooling agent
vaporisable
Prior art date
Application number
IL277973A
Other languages
English (en)
Hebrew (he)
Other versions
IL277973B1 (en
IL277973A (en
Original Assignee
Nicoventures Trading Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicoventures Trading Ltd filed Critical Nicoventures Trading Ltd
Publication of IL277973A publication Critical patent/IL277973A/en
Publication of IL277973B1 publication Critical patent/IL277973B1/en
Publication of IL277973B2 publication Critical patent/IL277973B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/10—Chemical features of tobacco products or tobacco substitutes
    • A24B15/16—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
    • A24B15/167—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes in liquid or vaporisable form, e.g. liquid compositions for electronic cigarettes
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/24—Treatment of tobacco products or tobacco substitutes by extraction; Tobacco extracts
    • A24B15/241—Extraction of specific substances
    • A24B15/243—Nicotine
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/281—Treatment of tobacco products or tobacco substitutes by chemical substances the action of the chemical substances being delayed
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A24B15/32—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances by acyclic compounds
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A24B15/34—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a carbocyclic ring other than a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A24B15/36—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring
    • A24B15/38—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring having only nitrogen as hetero atom
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A24B15/36—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring
    • A24B15/40—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring having only oxygen or sulfur as hetero atoms
    • A24B15/403—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring having only oxygen or sulfur as hetero atoms having only oxygen as hetero atoms
    • A24B15/406—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring having only oxygen or sulfur as hetero atoms having only oxygen as hetero atoms in a five-membered ring
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
    • A24F40/00—Electrically operated smoking devices; Component parts thereof; Manufacture thereof; Maintenance or testing thereof; Charging means specially adapted therefor
    • A24F40/10—Devices using liquid inhalable precursors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/006—Sprayers or atomisers specially adapted for therapeutic purposes operated by applying mechanical pressure to the liquid to be sprayed or atomised
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/06—Inhaling appliances shaped like cigars, cigarettes or pipes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Addiction (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pulmonology (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Mechanical Engineering (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Manufacture Of Tobacco Products (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL277973A 2018-05-03 2019-05-03 Evaporable formulation IL277973B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1807305.6A GB201807305D0 (en) 2018-05-03 2018-05-03 Vaporisable formulation
PCT/GB2019/051244 WO2019211629A1 (en) 2018-05-03 2019-05-03 Vaporisable formulation

Publications (3)

Publication Number Publication Date
IL277973A IL277973A (en) 2020-11-30
IL277973B1 IL277973B1 (en) 2023-10-01
IL277973B2 true IL277973B2 (en) 2024-02-01

Family

ID=62598261

Family Applications (2)

Application Number Title Priority Date Filing Date
IL277973A IL277973B2 (en) 2018-05-03 2019-05-03 Evaporable formulation
IL305868A IL305868B2 (en) 2018-05-03 2019-05-03 Evaporable formulation

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL305868A IL305868B2 (en) 2018-05-03 2019-05-03 Evaporable formulation

Country Status (13)

Country Link
US (1) US20210368850A1 (enExample)
EP (1) EP3787429A1 (enExample)
JP (2) JP7258911B2 (enExample)
KR (2) KR20230151065A (enExample)
CN (1) CN112074201A (enExample)
AU (2) AU2019264022A1 (enExample)
BR (1) BR112020021341A2 (enExample)
CA (2) CA3190409A1 (enExample)
GB (1) GB201807305D0 (enExample)
IL (2) IL277973B2 (enExample)
MX (1) MX2020011664A (enExample)
MY (1) MY203314A (enExample)
WO (1) WO2019211629A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12588700B2 (en) 2019-12-02 2026-03-31 Jt International Sa E-liquid composition comprising 1,3-propanediol below 50% by weight of the composition
GB202006633D0 (en) * 2020-05-05 2020-06-17 Nicoventures Holdings Ltd Aerosol generating material
US11771136B2 (en) 2020-09-28 2023-10-03 Rai Strategic Holdings, Inc. Aerosol delivery device
GB202110541D0 (en) * 2021-07-22 2021-09-08 Nicoventures Trading Ltd Delivery system
CA3242529A1 (en) * 2022-01-14 2023-07-20 Nicoventures Trading Limited Aerosolisable material

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070178123A1 (en) * 2006-01-27 2007-08-02 Deborah Levenson Flavor-enhancing compositions, method of manufacture, and methods of use
WO2014182736A1 (en) * 2013-05-06 2014-11-13 Ploom, Inc. Nicotine salt formulations for aerosol devices and methods thereof
US20150027454A1 (en) * 2013-07-24 2015-01-29 Altria Client Services Inc. Electronic smoking article
US20150313275A1 (en) * 2014-04-30 2015-11-05 Altria Client Services, Inc. Liquid aerosol formulation of an electronic smoking article
US20160376263A1 (en) * 2016-07-26 2016-12-29 Senomyx, Inc. Bitter taste modifiers including substituted 1-benzyl-3-(1-(isoxazol-4-ylmethyl)-1h-pyrazol-4-yl)imidazolidine-2,4-diones and compositions thereof
WO2017103136A1 (en) * 2015-12-18 2017-06-22 Philip Morris Products S.A. Strength enhancers and method of achieving strength enhancement in an electronic vapor device

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5097886A (enExample) * 1973-12-28 1975-08-04
JP2005512554A (ja) * 2001-12-19 2005-05-12 ベクター・タバコ・インコーポレーテッド タバコ製品に清涼効果を付与する方法および組成物
US6897195B2 (en) * 2002-07-24 2005-05-24 Nanjing Zhongshi Chemical Co. Composition of menthol and menthyl lactate, its preparation method and its applications as a cooling agent
CA2592635C (en) * 2004-12-29 2013-02-12 Wm. Wrigley Jr. Company Combinations of cooling agents for use in confections
WO2007041035A2 (en) 2005-09-30 2007-04-12 Wm. Wrigley Jr. Company Oral composition and method for stress reduction associated with smoking cessation
US20100056636A1 (en) 2006-12-20 2010-03-04 Stefan Michael Furrer N-Substituted-P-Menthane-3-Carboxamide and Uses Thereof
JP2009148233A (ja) 2007-12-21 2009-07-09 Japan Tobacco Inc 喫煙物品
WO2009140783A1 (en) * 2008-05-22 2009-11-26 Givaudan Sa Cooling composition
DE102010002558A1 (de) * 2009-11-20 2011-06-01 Symrise Ag Verwendung physiologischer Kühlwirkstoffe und Mittel enthaltend solche Wirkstoffe
ES2377785B2 (es) 2010-09-08 2012-09-26 Universidad Miguel Hernández De Elche Composición farmacéutica para el tratamiento del ojo seco.
US9854839B2 (en) * 2012-01-31 2018-01-02 Altria Client Services Llc Electronic vaping device and method
US20160128944A1 (en) * 2013-06-04 2016-05-12 Vyome Biosciences Pvt. Ltd. Coated particles and compositions comprising same
JP6061900B2 (ja) 2014-07-24 2017-01-18 長谷川香料株式会社 Ｗｓ−１２の微粒子およびこれを含有する冷感剤組成物
TWI693031B (zh) 2015-04-30 2020-05-11 瑞士商菲利浦莫里斯製品股份有限公司 包含具高通氣度之可卸式清新劑遞送元件的氣溶膠產生物件
GB2544468A (en) * 2015-11-12 2017-05-24 Jaytee Biosciences Ltd Liquid formulation
JP6770864B2 (ja) 2016-09-30 2020-10-21 アース製薬株式会社 スプレー型芳香剤
CN106962971A (zh) 2017-04-11 2017-07-21 深圳瀚星翔科技有限公司 电子烟烟油及其制备方法

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070178123A1 (en) * 2006-01-27 2007-08-02 Deborah Levenson Flavor-enhancing compositions, method of manufacture, and methods of use
WO2014182736A1 (en) * 2013-05-06 2014-11-13 Ploom, Inc. Nicotine salt formulations for aerosol devices and methods thereof
US20150027454A1 (en) * 2013-07-24 2015-01-29 Altria Client Services Inc. Electronic smoking article
US20150313275A1 (en) * 2014-04-30 2015-11-05 Altria Client Services, Inc. Liquid aerosol formulation of an electronic smoking article
WO2017103136A1 (en) * 2015-12-18 2017-06-22 Philip Morris Products S.A. Strength enhancers and method of achieving strength enhancement in an electronic vapor device
US20160376263A1 (en) * 2016-07-26 2016-12-29 Senomyx, Inc. Bitter taste modifiers including substituted 1-benzyl-3-(1-(isoxazol-4-ylmethyl)-1h-pyrazol-4-yl)imidazolidine-2,4-diones and compositions thereof

Also Published As

Publication number Publication date
JP7258911B2 (ja) 2023-04-17
RU2020136071A (ru) 2022-05-04
EP3787429A1 (en) 2021-03-10
IL305868B2 (en) 2025-03-01
JP7682942B2 (ja) 2025-05-26
NZ768771A (en) 2024-07-05
AU2022218470B2 (en) 2024-07-04
RU2020136071A3 (enExample) 2022-05-04
KR20230151065A (ko) 2023-10-31
KR102594623B1 (ko) 2023-10-25
CN112074201A (zh) 2020-12-11
JP2021523690A (ja) 2021-09-09
BR112020021341A2 (pt) 2021-01-19
US20210368850A1 (en) 2021-12-02
IL305868A (en) 2023-11-01
KR20200136033A (ko) 2020-12-04
AU2019264022A1 (en) 2020-10-29
IL277973B1 (en) 2023-10-01
IL277973A (en) 2020-11-30
CA3190409A1 (en) 2019-11-07
MX2020011664A (es) 2020-12-10
IL305868B1 (en) 2024-11-01
GB201807305D0 (en) 2018-06-20
CA3099021A1 (en) 2019-11-07
JP2023085453A (ja) 2023-06-20
WO2019211629A1 (en) 2019-11-07
MY203314A (en) 2024-06-24
AU2022218470A1 (en) 2022-09-08

Similar Documents

Publication Publication Date Title
IL277973B1 (en) Evaporable formulation
JP2023085453A5 (enExample)
CN103875673B (zh) 褪黑素在促进植物生长中的新应用
RU2015137146A (ru) Композиции для личной гигиены
RU2018138157A (ru) Раствор, содержащий никотин в непротонированной форме и протонированной форме
JP2011201907A5 (enExample)
MX384606B (es) Formulaciones de sal de nicotina para dispositivos de aerosol y métodos de los mismos.
JP2014526447A5 (enExample)
JP2022528221A5 (enExample)
PH12015502542A1 (en) Stabilized pemetrexed formulation
PH12014502746A1 (en) Dry powder for inhalation formulation comprising salmeterol xinafoate, fluticasone propionate and tiotropium bromide, and method for preparing same
EP4454708A3 (en) A tablet comprising a methoxyurea derivative and mannitol particles
PH12017500136A1 (en) Long-chain dimethylaniline derivative compounds, their preparation methods, self-assembled textures, and uses thereof
JP2015098469A5 (enExample)
CN105212273A (zh) 一种电子烟烟油软胶囊
RU2018111436A (ru) Композиция для поддержания доминирования лактобактерий
CN103960253A (zh) 含敌稗、异噁草松的水稻田除草剂组合物
CN103865276A (zh) 一种具有控制释放功能的活性抗菌可食包装及其制备方法
WO2012173458A3 (ko) 식물 세포 내에 안정화된 활성 물질 및 그 제조방법
JP2018188399A (ja) テリパラチドのプレフィルドシリンジ製剤
PE20170690A1 (es) Formulacion de polvo seco
JP6501399B2 (ja) ペメトレキセドを含有する注射用溶液製剤
IL274138B2 (en) Evaporable perfumed formulation
CN102696600A (zh) 一种含2,4-滴与麦草畏的除草组合物及其制备方法和应用
WO2016036966A8 (en) Hydrazinyl lipidoids and uses thereof